COMPASS Pathways plc
CMPS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001816590
No open-market purchases or sales by COMPASS Pathways plc insiders were filed in the last 90 days; 224 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in COMPASS Pathways plc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- −7 vs. Q4 2023
- Shares held
- 27.5M
- +4.73M (+20.8%) vs. Q4 2023
- Total value
- $228.1M
- +$29.1M (+14.6%) vs. Q4 2023
- New holders
- 19
- 26 more added
- Sold out
- 26
- 26 more reduced
3 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 224 | $1.28B |
| Q1 2026 | 194 | $511.5M |
| Q4 2025 | 168 | $379.2M |
| Q3 2025 | 157 | $318.0M |
| Q2 2025 | 140 | $145.1M |
| Q1 2025 | 135 | $148.4M |
| Q4 2024 | 132 | $117.0M |
| Q3 2024 | 130 | $206.5M |
| Q2 2024 | 122 | $172.3M |
| Q1 2024 | 116 | $228.1M |
| Q4 2023 | 126 | $201.1M |
| Q3 2023 | 113 | $164.9M |
| Q2 2023 | 97 | $68.7M |
| Q1 2023 | 103 | $81.3M |
| Q4 2022 | 111 | $61.0M |
| Q3 2022 | 115 | $80.2M |
| Q2 2022 | 108 | $73.8M |
| Q1 2022 | 109 | $99.9M |
| Q4 2021 | 126 | $167.0M |
| Q3 2021 | 118 | $228.7M |
| Q2 2021 | 111 | $294.8M |
| Q1 2021 | 83 | $182.2M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding COMPASS Pathways plc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sumitomo Mitsui Trust Holdings, Inc. | 327,204 | $2.72M | 0.00% | −37,758−10.3% | Reduced |
| BlackRock Inc. | 327,813 | $2.73M | 0.00% | +22,590+7.4% | Added |
| Barclays PLC | 410,476 | $3.42M | 0.00% | −90,834−18.1% | Reduced |
| Laurion Capital Management LP | 510,907 | $4.25M | 0.12% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 565,550 | $4.71M | 0.41% | −399,000−41.4% | Reduced |
| Rosalind Advisors, Inc. | 734,000 | $6.11M | 5.71% | −64,500−8.1% | Reduced |
| Ra Capital Management, L.P. | 791,359 | $6.58M | 0.08% | −494,641−38.5% | Reduced |
| Aisling Capital Management LP | 964,500 | $8.02M | 2.72% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 1,027,868 | $8.55M | 1.39% | +477,868+86.9% | Added |
| PFM Health Sciences, LP | 1,089,592 | $9.07M | 0.45% | +750,831+221.6% | Added |
| Vivo Capital, LLC | 1,608,000 | $13.4M | 1.05% | 00.0% | Unchanged |
| ARK Investment Management LLCSuperinvestorARK Invest | 2,161,234 | $18.0M | 0.12% | −457,637−17.5% | Reduced |
| Paradigm Biocapital Advisors LP | 2,390,988 | $19.9M | 0.70% | +125,000+5.5% | Added |
| Millennium Management LLC | 3,225,545 | $26.8M | 0.02% | +3,120,656+2,975.2% | Added |
| Citadel Advisors LLC | 3,856,324 | $32.1M | 0.03% | +2,291,324+146.4% | Added |
| TCG Crossover Management, LLC | 3,858,000 | $32.1M | 2.54% | 00.0% | Unchanged |
| Householder Group Estate & Retirement Specialist, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Princeton Global Asset Management LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −277,209−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −265,613−100.0% | Sold out |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −251,532−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −110,939−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −53,587−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −49,959−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −48,419−100.0% | Sold out |
| Sculptor Capital LP | 0 | $0 | 0.00% | −44,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −42,400−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −19,493−100.0% | Sold out |
| AE Wealth Management LLC | 0 | $0 | 0.00% | −14,024−100.0% | Sold out |
| Ewa, LLC | 0 | $0 | 0.00% | −12,272−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −14,653−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −3,800−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −2,296−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −1,480−100.0% | Sold out |
| LM Advisors LLC | 0 | $0 | 0.00% | −118−100.0% | Sold out |
| Gradient Investments LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Lee Financial Co | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| SJS Investment Consulting Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Putnam Investments LLC | – | – | – | – | Not filed |
| Baystate Wealth Management LLC | – | – | – | – | Not filed |
| Nalls Sherbakoff Group, LLC | – | – | – | – | Not filed |